AI
insitro unveiled a $143 million Series B round on the same day that fellow machine learning company Exscientia highlighted its own $60 million Series C raise.
AI is steadily proving itself to the clinical community, but there are some aspects of care in which an algorithm will never be granted full control, said Cardiologs CEO Yann Fleureau.
A new study suggests that a deep learning system would save on the roughly two minutes of human labor required to grade each case, although a semi-automated approach was found to drive the greatest savings for large programs.
Epstein Becker & Green's Bradley Merrill Thompson describes the agency's current trajectory for regulation of patient-facing and provider-facing telehealth products that incorporate AI.
They signed deals with MaQuestionMedicale in France and HomeDoctor in Spain.
COVID-19
Also, tech-enabled home care provider Cera has concluded research into the performance of AI in comparison to human clinicians.
Certain healthcare use cases are ripe for AI, but still must provide a human touch to truly benefit patient experience.
The AI company now has a presence among more than 500 U.S. hospitals.
The Auto Ejection Fraction Tool and the Auto Bladder Volume Tool both employed AI to help Butterfly iQ users more easily evaluate the patient's condition.
The Series A raise comes just a few months after the company raised $3 million in seed funding.